Literature DB >> 6548107

Identification of Thormählen-positive compound "B" in urine of patients with malignant melanoma.

S Pavel, R Boverhof, W van der Slik.   

Abstract

The identification of the entire structure of the Thormählen-positive compound B from melanotic urine is described. The compound was separated from other Thormählen-positive compounds using DEAE-cellulose column chromatography. On the basis of differential enzymic hydrolysis followed by gas chromatography-mass spectrometry analysis and comparison with synthetically prepared compounds it is possible to conclude that the Thormählen-positive compound B is a mixture of O-sulphate 5-hydroxy-6-methoxyindole and 6-hydroxy-5-methoxyindole with predominance of the latter.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548107     DOI: 10.1007/bf00414012

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

1.  Identification of two Thormählen-positive compounds from melanotic urine by gas chromatography-mass spectrometry.

Authors:  S Pavel; F A Muskiet; G T Nagel; Z Schwippelová; J Duchon
Journal:  J Chromatogr       Date:  1981-03-13

2.  Urinary phenols in melanoma.

Authors:  R F Coward; P Smith; J E Middleton
Journal:  Nature       Date:  1967-02-04       Impact factor: 49.962

3.  Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry.

Authors:  S Pavel; F A Muskiet; L de Ley; T H The; W van der Slik
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.

Authors:  S Pavel; F A Muskiet
Journal:  Cancer Detect Prev       Date:  1983

5.  A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.

Authors:  S Pavel; F A Muskiet; A Budesínská; J Duchon
Journal:  Tumori       Date:  1981-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.